Series of RXMD events: 1. Uplist to OTCQB December 2017. 2. Severe reduction in Key Pharmacist salary/bonus structure confirmed 3/22/2018. 3. ANNOUNCEMENT AND COMPLETION of first acquisition in March 2018. 4.Creation of DischargeRx program in 2018. 5. Completion of Telepharmacy platform in 2018. 6. Second Reduction in key pharmacist salary in August 2018. 7. Purchase of new headquarters in 2018. 8. Announcement of 3rd and 4th location acquisitions in December 2018. 9. 2 million shares sold @ $.019 on January 23, 2018
Thanks JimmyQuick for the concise round-up of current key events on RXMD. All of these very positive developments are clearly contributing to the steady appreciation in the stock price we are seeing here. I am especially looking forward to more news on the new pharmacy acquisitions since they will dramatically boost the company revenues for 2019.
Series of RXMD events: 1. Uplist to OTCQB December 2017. 2. Severe reduction in Key Pharmacist salary/bonus structure confirmed 3/22/2018. 3. ANNOUNCEMENT AND COMPLETION of first acquisition in March 2018. 4.Creation of DischargeRx program in 2018. 5. Completion of Telepharmacy platform in 2018. 6. Second Reduction in key pharmacist salary in August 2018. 7. Purchase of new headquarters in 2018. 8. Announcement of 3rd and 4th location acquisitions in December 2018. 9. 2 million shares sold @ $.019 on January 23, 2018